Literature DB >> 20889528

Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.

K I Papageorgiou1, V M L Cohen, C Bunce, M Kinsella, J L Hungerford.   

Abstract

BACKGROUND: We evaluated the control rate of choroidal melanomas treated with ¹⁰⁶Ru plaque brachytherapy to identify the risk factors associated with local recurrence and lack of response.
METHODS: A retrospective review of ¹⁰⁶Ru plaque brachytherapy for patients with choroidal melanoma treated at St Bartholomew's Hospital, London. Survival analysis was used to assess associations between evaluated age, sex, location, foveal proximity, tumour base and height, presence of lipofuscin and subretinal fluid, apex dose, radiation rate and type of plaque with time to local recurrence. Logistic regression analysis was used to assess to evaluate the association between the same set of variables and lack of tumour response.
RESULTS: From January 2002 to December 2006 189 patients were treated. The follow-up ranged from 12 to 78 (median 33) months. None of the patients received adjuvant diode laser thermotherapy. The control rate was 85.7% (14 recurred while 13 did not respond). Of the patients who had local recurrence, univariate survival analysis demonstrated an association with younger patients, foveal proximity, preoperative subfoveal fluid and tumour base >11 mm. Age and foveal proximity remained significant in a Cox multiple variable model (p=0.03). Of the patients who did not respond, logistic regression analysis showed that lack of response was associated with a tumour height >5 mm, confirmed through multiple variable analysis (p=0.027).
CONCLUSIONS: Tumours that are close to the fovea in young patients appear more likely to show local recurrence. Tumour height >5 mm was the only prognostic factor that determined lack of response. These results may be used to select which tumours require adjuvant therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20889528     DOI: 10.1136/bjo.2009.176198

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland.

Authors:  S N Chia; H B Smith; H M Hammer; E G Kemp
Journal:  Eye (Lond)       Date:  2015-03-20       Impact factor: 3.775

2.  Intrasclera schwannoma.

Authors:  Hamid Hosseini; Masoomeh Eghtedari; Mohammad Roozitalab; Mohammad Ashraf; Sahabaldin Shahrzad
Journal:  BMJ Case Rep       Date:  2011-03-03

3.  Management of uveal melanoma: a consensus-based provincial clinical practice guideline.

Authors:  E Weis; T G Salopek; J G McKinnon; M P Larocque; C Temple-Oberle; T Cheng; J McWhae; R Sloboda; M Shea-Budgell
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

4.  Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma.

Authors:  Andrea Russo; Michela Laguardia; Bertil Damato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-23       Impact factor: 3.117

5.  Ruthenium-106 plaque radiotherapy for uveal melanoma: analysis of tumor dimension and location on anatomical and functional results.

Authors:  Reza Mirshahi; Ahad Sedaghat; Ramin Jaberi; Zohreh Azma; Mehdi Mazloumi; Masood Naseripour
Journal:  BMC Ophthalmol       Date:  2022-07-16       Impact factor: 2.086

6.  Uveal melanoma.

Authors:  Vasilios P Papastefanou; Victoria M L Cohen
Journal:  J Skin Cancer       Date:  2011-06-30

Review 7.  Uveal Melanoma: Current Trends in Diagnosis and Management.

Authors:  Berçin Tarlan; Hayyam Kıratlı
Journal:  Turk J Ophthalmol       Date:  2016-06-06

Review 8.  Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis.

Authors:  Saeed Karimi; Amir Arabi; Zahra Siavashpour; Toktam Shahraki; Iman Ansari
Journal:  J Contemp Brachytherapy       Date:  2021-05-18

Review 9.  Local treatment failure after globe-conserving therapy for choroidal melanoma.

Authors:  Melinda Y Chang; Tara A McCannel
Journal:  Br J Ophthalmol       Date:  2013-05-03       Impact factor: 4.638

10.  Prognostic factors of choroidal melanoma in Slovenia, 1986-2008.

Authors:  Boris Jancar; Marjan Budihna; Brigita Drnovsek-Olup; Katrina Novak Andrejcic; Irena Brovet Zupancic; Dusica Pahor
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.